“Future research should explore the complex interplay between COPD and RCC mortality risk, focusing on shared inflammatory pathways, treatment complications, and personalized management,” Dr ...

For patients with type 2 diabetes (T2D) and chronic obstructive pulmonary disorder (COPD), sodium-glucose cotransporter-2 ...

A new study has found that people who have type ... better options for patients with diabetes and COPD,” Patorno said. “This could influence treatment decisions and improve respiratory health ...

Researchers found that the risk for moderate or ... among patients aged 40 years or older with T2D and active COPD who initiated treatment with SGLT-2is vs DPP-4is; GLP-1 RAs vs DPP-4is; and ...

Verona Pharma will host an investment community webcast and conference call at 9:00 a.m. EST / 2:00 p.m. GMT on Thursday, ...

The Institute for Clinical and Economic Review has prepared a special report on Trelegy and Breo, two therapies that treat ...

Healio: Healio previously reported on a study that found that respiratory-specific ... There is no curative treatment of COPD, and anything that can reduce the decline in lung function could ...

Lower risk for COPD ... treatment with SGLT-2is versus DPP-4is; GLP-1 RAs versus DPP-4is; and SGLT-2is versus GLP-1 RAs (27,991; 32,107; and 36,218 pairs, respectively). The researchers found ...

Chronic Obstructive Pulmonary disease (COPD) has been around for almost 205 years and is one of the most prevalent non-infectious diseases in our country. It is the 2nd leading cause of death and ...

One study found that most people are at risk for developing DVT on one out of every 4,656 long flights, which is a relatively ...